BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greco E, Nanji S, Bromberg IL, Shah S, Wei AC, Moulton CA, Greig PD, Gallinger S, Cleary SP. Predictors of peri-opertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease. HPB (Oxford). 2011;13:559-565. [PMID: 21762299 DOI: 10.1111/j.1477-2574.2011.00329.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Sakka SG. Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients. J Clin Monit Comput 2018;32:787-96. [PMID: 29039062 DOI: 10.1007/s10877-017-0073-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
2 Kudo M. Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm. Liver Cancer 2017;6:185-8. [PMID: 28626730 DOI: 10.1159/000462199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
3 Halle BM, Poulsen TD, Pedersen HP. Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients. Acta Anaesthesiol Scand. 2014;58:1214-1219. [PMID: 25307706 DOI: 10.1111/aas.12406] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
4 Chung HS, Lee S, Kwon SJ, Park CS. Perioperative predictors for refractory hyperglycemia during the neohepatic phase of liver transplantation. Transplant Proc. 2014;46:3474-3480. [PMID: 25498075 DOI: 10.1016/j.transproceed.2014.06.078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Yu D, Chen W, Jiang C, Ding Y. Risk assessment in patients undergoing liver resection. Hepatobiliary & Pancreatic Diseases International 2013;12:473-9. [DOI: 10.1016/s1499-3872(13)60075-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
6 Vos JJ, Wietasch JK, Absalom AR, Hendriks HG, Scheeren TW. Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia. 2014;69:1364-1376. [PMID: 24894115 DOI: 10.1111/anae.12755] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
7 De Gasperi A, Mazza E, Prosperi M. Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery? World J Hepatol 2016; 8(7): 355-367 [PMID: 26981173 DOI: 10.4254/wjh.v8.i7.355] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
8 Rahbari NN, Birgin E, Sturm D, Schwanebeck U, Weitz J, Reissfelder C. Randomized clinical trial of BioFoam® Surgical Matrix to achieve hemostasis after liver resection. HPB (Oxford) 2020;22:987-95. [PMID: 31680010 DOI: 10.1016/j.hpb.2019.10.1529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Imai K, Yamashita YI, Nakao Y, Matsumoto T, Kinoshita S, Yusa T, Kitano Y, Kaida T, Hayashi H, Baba H. Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function? Ann Surg Oncol 2021;28:854-62. [PMID: 32740735 DOI: 10.1245/s10434-020-08960-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sucandy I, Giovannetti A, Spence J, Ross S, Rosemurgy A. Does preoperative MELD score affect outcomes following robotic hepatectomy for liver tumors? J Robot Surg 2020;14:725-31. [PMID: 31989441 DOI: 10.1007/s11701-020-01046-x] [Reference Citation Analysis]
11 Chen Q, Merath K, Bagante F, Akgul O, Dillhoff M, Cloyd J, Pawlik TM. A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population. J Gastrointest Surg 2018;22:2088-96. [PMID: 30039449 DOI: 10.1007/s11605-018-3883-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
12 Conrad C, Tanabe KK. Patient selection, resection, and outcomes for hepatocellular carcinoma. Am Soc Clin Oncol Educ Book 2012;:265-9. [PMID: 24451746 DOI: 10.14694/EdBook_AM.2012.32.9] [Reference Citation Analysis]
13 Cai T, Deng Q, Zhang S, Hu A, Gong Q, Zhang X. Peripheral blood stem cell transplantation improves liver functional reserve. Med Sci Monit 2015;21:1381-6. [PMID: 25970080 DOI: 10.12659/MSM.892990] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K; Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer 2017;6:204-15. [PMID: 28626732 DOI: 10.1159/000452846] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 15.4] [Reference Citation Analysis]
15 Ross SW, Seshadri R, Walters AL, Augenstein VA, Heniford BT, Iannitti DA, Martinie JB, Vrochides D, Swan RZ. Mortality in hepatectomy: Model for End-Stage Liver Disease as a predictor of death using the National Surgical Quality Improvement Program database. Surgery 2016;159:777-92. [PMID: 26474653 DOI: 10.1016/j.surg.2015.08.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
16 Dasari BVM, Wilson M, Pufal K, Kadam P, Hodson J, Roberts KJ, Chatzizacharias N, Marudanayagam R, Gadvi R, Sutcliffe RP, Mirza DF, Muiesan P, Isaac J. Variations between the anatomical and functional distribution, based on 99m technetium -mebrofinate SPECT-CT scan, in patients at risk of post hepatectomy liver failure. HPB (Oxford) 2021:S1365-182X(21)00114-3. [PMID: 33975803 DOI: 10.1016/j.hpb.2021.04.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Hoetzel A, Ryan H, Schmidt R. Anesthetic considerations for the patient with liver disease. Curr Opin Anaesthesiol. 2012;25:340-347. [PMID: 22450699 DOI: 10.1097/aco.0b013e3283532b02] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
18 Li M, Wang J, Song J, Shen F, Song L, Ni X, Suo T, Liu H, Zhong M, Liu H. Preoperative ICG Test to Predict Posthepatectomy Liver Failure and Postoperative Outcomes in Hilar Cholangiocarcinoma. Biomed Res Int 2021;2021:8298737. [PMID: 33681380 DOI: 10.1155/2021/8298737] [Reference Citation Analysis]
19 Zhang Y, Wang J, Ji H, Lu H, Lu L, Wang J, Li Y. Effect of HSP27 and Cofilin in the injury of hypoxia/reoxygenation on hepatocyte membrane F-actin microfilaments. Medicine (Baltimore) 2017;96:e6658. [PMID: 28422872 DOI: 10.1097/MD.0000000000006658] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Sunagawa Y, Yamada S, Kato Y, Sonohara F, Takami H, Inokawa Y, Hayashi M, Nakayama G, Koike M, Kodera Y. Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci 2021;28:86-94. [PMID: 33052632 DOI: 10.1002/jhbp.833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Li J, Lei B, Nie X, Lin L, Tahir SA, Shi W, Jin J, He S. A comprehensive method for predicting fatal liver failure of patients with liver cancer resection. Medicine (Baltimore) 2015;94:e784. [PMID: 25929924 DOI: 10.1097/MD.0000000000000784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Farid SG, Prasad KR, Morris-Stiff G. Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives. World J Gastrointest Surg 2013; 5(5): 146-155 [PMID: 23710292 DOI: 10.4240/wjgs.v5.i5.146] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
23 Tomassini F, Giglio MC, De Simone G, Montalti R, Troisi RI. Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review. Updates Surg 2020;72:925-38. [PMID: 32749596 DOI: 10.1007/s13304-020-00859-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Costa AF, Tremblay St-Germain A, Abdolell M, Smoot RL, Cleary S, Jhaveri KS. Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection? Clin Radiol 2017;72:598-605. [PMID: 28274510 DOI: 10.1016/j.crad.2017.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
25 Zou H, Yang X, Li QL, Zhou QX, Xiong L, Wen Y. A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients. Dig Dis 2018;36:236-43. [PMID: 29495004 DOI: 10.1159/000486590] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
26 Costa AF, Tremblay St-germain A, Abdolell M, Smoot RL, Cleary S, Jhaveri KS. How Do Different Indices of Hepatic Enhancement With Gadoxetic Acid Compare in Predicting Liver Failure and Other Major Complications After Hepatectomy?: . Journal of Computer Assisted Tomography 2018;42:380-6. [DOI: 10.1097/rct.0000000000000691] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
27 Fromer MW, Aloia TA, Gaughan JP, Atabek UM, Spitz FR. The utility of the MELD score in predicting mortality following liver resection for metastasis. Eur J Surg Oncol 2016;42:1568-75. [PMID: 27365199 DOI: 10.1016/j.ejso.2016.05.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
28 Oishi K, Itamoto T, Kohashi T, Matsugu Y, Nakahara H, Kitamoto M. Safety of hepatectomy for elderly patients with hepatocellular carcinoma. World J Gastroenterol 2014; 20(41): 15028-15036 [PMID: 25386051 DOI: 10.3748/wjg.v20.i41.15028] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
29 Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, Azoulay D. Current use and perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain Med. 2016;35:49-57. [PMID: 26477363 DOI: 10.1016/j.accpm.2015.06.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
30 Ardito F, Famularo S, Aldrighetti L, Grazi GL, DallaValle R, Maestri M, Jovine E, Ruzzenente A, Baiocchi GL, Ercolani G, Griseri G, Frena A, Zanus G, Zimmitti G, Antonucci A, Crespi M, Memeo R, Romano F, Giuliante F; HE.RC.O.LE.S. Group. The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry. Ann Surg 2020;272:840-6. [PMID: 32889868 DOI: 10.1097/SLA.0000000000004327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]